For better experience, turn on JavaScript!


Daily News on Precision medicine


Gemini Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

2021-04-13 12:06:24 UTC

Gemini Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)CAMBRIDGE, Mass.--(BUSINESS WIRE)--Gemini Therapeutics, Inc. (Nasdaq: GMTX), a clinical stage precision medicine company developing innovative treatments for genetically defined age-related macular degeneration (AMD), today announced the grant of an inducemen Read more at Business Wire


Gemini Therapeutics Appoints Samuel Barone, M.D., as Chief Medical Officer

2021-04-12 12:08:17 UTC

Gemini Therapeutics Appoints Samuel Barone, M.D., as Chief Medical OfficerCAMBRIDGE, Mass.--(BUSINESS WIRE)--Gemini Therapeutics, Inc. (Nasdaq: GMTX), a clinical stage precision medicine company developing innovative treatments for genetically defined age-related macular degeneration (AMD) and linked ocular disorders, today announc Read more at Business Wire


Genialis Presents Updated Results on AI-Enabled, RNA-Based Pan-Cancer Biomarker Platform at AACR

2021-04-12 12:08:17 UTC

Genialis Presents Updated Results on AI-Enabled, RNA-Based Pan-Cancer Biomarker Platform at AACRBOSTON--(BUSINESS WIRE)-- #AACR--Genialis announced its contributions to a biomarker platform and panel that demonstrated prognostic capabilities for colorectal cancer. Read more at Business Wire


AMRA Medical Generates Largest Imaging Dataset on Body Composition Profiling

2021-04-14 13:30:00 UTC

AMRA Medical Generates Largest Imaging Dataset on Body Composition ProfilingToday, AMRA Medical announced an expansion of its dataset, resulting from a collaboration with Pfizer Inc. and UK Biobank, from 10,000 to 25,000 UK Biobank... Read more at Yahoo Entertainment


Tango Therapeutics to go public in $353 million SPAC deal

2021-04-14 13:16:52 UTC

Tango Therapeutics to go public in $353 million SPAC dealTango launched out of Third Rock Ventures in 2017 and its cancer therapies are in the preclinical stage. With the SPAC deal, Tango plans to accelerate its lead candidate into the clinic in the fourth quarter of this year. Read more at The Boston Globe


Precision BioSciences Appoints Stanley R. Frankel, M.D. to Board of Directors

2021-04-12 11:24:24 UTC

Precision BioSciences Appoints Stanley R. Frankel, M.D. to Board of DirectorsDURHAM, N.C.--(BUSINESS WIRE)--Stanley R. Frankel, M.D. has been appointed to the Board of Directors for Precision BioSciences.
Read more at Business Wire


Diaceutics Appoints Yvanka Gilliam as Vice President of Operations, Asia Pacific

2021-04-12 14:08:45 UTC

Diaceutics Appoints Yvanka Gilliam as Vice President of Operations, Asia PacificPARSIPPANY, N.J.--(BUSINESS WIRE)--Diaceutics PLC, (AIM: DXRX), today announces the appointment of Yvanka Gilliam as Vice President of Operations, Asia Pacific (APAC). Read more at Business Wire


Virtual Digi-Tech Pharma & AI Conference 2021, May 5th-6th, 2021 - ResearchAndMarkets.com - Business Wire

2021-04-12 14:38:00 UTC

Virtual Digi-Tech Pharma & AI Conference 2021, May 5th-6th, 2021 - ResearchAndMarkets.com - Business WireVirtual Digi-Tech Pharma & AI Conference 2021, May 5th-6th, 2021 - ResearchAndMarkets.comBusiness Wire
Read more at Business Wire


Virtual Digi-Tech Pharma & AI Conference 2021, May 5th-6th, 2021 - ResearchAndMarkets.com - Yahoo Finance

2021-04-12 14:38:00 UTC

Virtual Digi-Tech Pharma & AI Conference 2021, May 5th-6th, 2021 - ResearchAndMarkets.com - Yahoo FinanceVirtual Digi-Tech Pharma & AI Conference 2021, May 5th-6th, 2021 - ResearchAndMarkets.comYahoo Finance
Read more at Yahoo Entertainment


Study to see if Apple Watch can detect COVID-19 now taking volunteers

2021-04-14 10:54:45 UTC

Study to see if Apple Watch can detect COVID-19 now taking volunteersThe eligibility criteria are pretty narrow, however! What you need to know Apple announced an Apple Watch study to see if the device can detect diseases like COVID-19 back in September. A study in partnership with the University of Washington and Seattle F Read more at iMore


4 Spectacular Stocks That'll Make You Bank in a Biden Bull Market

2021-04-11 09:51:00 UTC

4 Spectacular Stocks ThatThese game-changing companies can stand out in a big way under the new administration.
Read more at Motley Fool


Cancer DNA blood tests validated by international research team

2021-04-12 04:00:00 UTC

Cancer DNA blood tests validated by international research teamResearchers have independently validated industry-leading blood tests that can detect the DNA released by tumours.
Read more at EurekAlert


Kathy Giusti, MMRF Founder & Chief Mission Officer, named recipient of American Association for Cancer Research Distinguished Public Service Award

2021-04-12 13:54:56 UTC

Kathy Giusti, MMRF Founder & Chief Mission Officer, named recipient of American Association for Cancer Research Distinguished Public Service AwardNORWALK, Conn.--(BUSINESS WIRE)-- #AACR2021--Kathy Giusti wins American Association for Cancer Research [AACR] Distinguished Public Service Award Read more at Business Wire


Anavex Life Sciences Reports the Results of Review by the Independent Data Safety Monitoring Board for its Phase 2/3 Trials of ANAVEX2-73 in Patients with Rett Syndrome

2021-04-12 11:00:00 UTC

Anavex Life Sciences Reports the Results of Review by the Independent Data Safety Monitoring Board for its Phase 2/3 Trials of ANAVEX2-73 in Patients with Rett SyndromeNEW YORK, April 12, 2021 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (Anavex or the Company) (Nasdaq: AVXL), a clinical-stage biopharmaceutical... Read more at Yahoo Entertainment


Spit samples uncover genetic risk factors for pediatric obsessive-compulsive disorder

2021-04-12 14:19:08 UTC

Spit samples uncover genetic risk factors for pediatric obsessive-compulsive disorderResearchers have discovered genetic risk factors for OCD that could help pave the way for earlier diagnosis and improved treatment for children and youth. Saliva samples from 5,000 kids were scanned and compared to responses using the Toronto Obsessive-Compul Read more at Science Daily


New clinical study shows Nevisense potential for assessment of Skin Barrier and Atopic Dermatitis

2021-04-12 06:09:00 UTC

New clinical study shows Nevisense potential for assessment of Skin Barrier and Atopic DermatitisSciBase Holding AB ("SciBase") [STO:SCIB], a leading developer of augmented intelligence-based solutions for skin disorders, announced today the publication ... Read more at Yahoo Entertainment


AI-powered precision drug dosing can boost outcomes and cost efficiency

2021-04-12 00:00:00 UTC

AI-powered precision drug dosing can boost outcomes and cost efficiencyArtificial intelligence is the key in one technology's ability to administer less medication, thus putting patients at reduced risk and lowering medication costs. Read more at Healthcare IT News


Global Clinical Genomics Markets Report 2021: Mergers, Acquisitions, and Partnerships Accelerate Adoption of Clinical Genomics

2021-04-14 08:13:00 UTC

Global Clinical Genomics Markets Report 2021: Mergers, Acquisitions, and Partnerships Accelerate Adoption of Clinical GenomicsDublin, April 14, 2021 (GLOBE NEWSWIRE) -- The "Clinical Genomics Report: The Interplay Between Clinical Research & Clinical Diagnostics" report has been... Read more at Yahoo Entertainment


OpGen Announces Results from Successful Webinar on Bacterial Pneumonia Co-infections in COVID-19 Patients

2021-04-12 11:30:00 UTC

OpGen Announces Results from Successful Webinar on Bacterial Pneumonia Co-infections in COVID-19 PatientsExperts presented the results of their Unyvero studies and demonstrated: Distinguishing those COVID-19 ICU patients with bacterial superinfection early and... Read more at Yahoo Entertainment


Genetron Health Releases 22 New Research Results at American Association for Cancer Research Annual Meeting (AACR) 2021

2021-04-13 05:37:47 UTC

Genetron Health Releases 22 New Research Results at American Association for Cancer Research Annual Meeting (AACR) 2021BEIJING--(BUSINESS WIRE)--Genetron Holdings Limited (Genetron Health or the Company, NASDAQ:GTH), a leading precision oncology platform company in China that specializes in molecular profiling tests, early cancer screening products and companion diagnosti Read more at Business Wire



Powered by NewsAPI.org